Evidence map›Paper›PMID 30654821›Full record

ArticleJournal of neuroinflammation2019

Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury.

Victoria L DiBona, Wenxin Zhu, Mihir K Shah, Aditi Rafalia, Hajer Ben Cheikh, David P Crockett, Huaye Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Neuronal connectivity, behavioral, and transcriptional alterations associated with the loss of MARK2.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  3. Review
  4. Article
  5. Brain communications · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Victoria L DiBonaDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0002-1914-2506
Wenxin ZhuDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
Mihir K ShahDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
Aditi RafaliaDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
Hajer Ben CheikhDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
David P CrockettDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0002-8137-755X
Huaye ZhangDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA. huaye.zhang@rutgers.edu.ORCID http://orcid.org/0000-0002-4844-6111
Rutgers, The State University of New Jersey · US

Funding

IRACDA at Rutgers: INSPIRE Postdoctoral Training ProgramK12GM093854 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Detlev Boison, Gary A. Brewer · 2010 to 2026
$14.7M
Polarity determinants in synaptic stability and plasticityR01NS089578 · NINDS · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI ZHANG, HUAYE · 2015 to 2019
$1.9M
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and FunctionR00NS065183 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ZHANG, HUAYE · 2011 to 2013
$738k
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and FunctionK99NS065183 · NINDS · UNIVERSITY OF VIRGINIA · PI ZHANG, HUAYE · 2009 to 2010
$180k
National Institute of General Medical Sciences 1K12GM093854National Institute of Neurological Disorders and Stroke NS065183National Institute of Neurological Disorders and Stroke NS089578New Jersey Commission on Brain Injury Research CBIR14FEL001NIGMS NIH HHS K12 GM093854NINDS NIH HHS K99 NS065183NINDS NIH HHS R00 NS065183NINDS NIH HHS R01 NS089578U.S. Department of Defense W81XWH1810388
6 · The paper itself

Abstract

backgroundMicroglia, the resident immune cells of the brain, exhibit various morphologies that correlate with their functions under physiological and pathological conditions. In conditions such as aging and stress, microglia priming occurs, which leads to altered morphology and lower threshold for activation upon further insult. However, the molecular mechanisms that lead to microglia priming are unclear.

methodsTo understand the role of Par1b/MARK2 in microglia, we first expressed shRNA targeting luciferase or Par1b/MARK2 in primary microglial cells and imaged the cells using fluorescent microscopy to analyze for morphological changes. A phagocytosis assay was then used to assess functional changes. We then moved in vivo and used a Par1b/MARK2 knockout mouse model to assess for changes in microglia density, morphology, and phagocytosis using immunohistochemistry, confocal imaging, and 3D image reconstruction. Next, we used two-photon in vivo imaging in live Par1b/MARK2 deficient mice to examine microglia dynamics. In addition, a controlled-cortical impact injury was performed on wild-type and Par1b/MARK2-deficient mice and microglial response was determined by confocal imaging. Finally, to help rule out non-cell autonomous effects, we analyzed apoptosis by confocal imaging, cytokine levels by multiplex ELISA, and blood-brain barrier permeability using Evans Blue assay.

resultsHere, we show that loss of the cell polarity protein Par1b/MARK2 facilitates the activation of primary microglia in culture. We next found that microglia in Par1b/MARK2 deficient mice show increased density and a hypertrophic morphology. These morphological changes are accompanied with alterations in microglia functional responses including increased phagocytosis of neuronal particles early in development and decreased surveillance of the brain parenchyma, all reminiscent of a primed phenotype. Consistent with this, we found that microglia in Par1b/MARK2 deficient mice have a significantly lower threshold for activation upon injury.

conclusionsTogether, our studies show that loss of Par1b/MARK2 switches microglia from a surveillant to a primed state during development, resulting in an increased neuroinflammatory response to insults.

Indexed as

Adenosine TriphosphateAnimalsAnimals, NewbornApoptosisBrainBrain Injuries, TraumaticCell Cycle ProteinsCells, CulturedComputer SimulationCX3C Chemokine Receptor 1Disease Models, AnimalGene Expression Regulation, DevelopmentalMiceMice, TransgenicMicrogliaModels, NeurologicalAdenosine TriphosphateCell Cycle ProteinsCX3C Chemokine Receptor 1Cx3cr1 protein, mouseMark2 protein, mouseProtein Serine-Threonine KinasesRNA, Small InterferingSynapsinsInjuryMARK2MicrogliaPar1bPriming

Identifiers

PMID30654821
PMCPMC6335724
OpenAlexW2917223490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.